Idioma:

Clinicopathologic Analysis of Breast Cancers with PIK3CA Mutations in Japanese Women

MARUYAMA, Naomi ; MIYOSHI, Yasuo ; TAGUCHI, Tetsuya ; TAMAKI, Yasuhiro ; MONDEN, Morito ; NOGUCHI, Shinzaburo

Clinical cancer research, 2007-01, Vol.13 (2), p.408-414 [Periódico revisado por pares]

Philadelphia, PA: American Association for Cancer Research

Texto completo disponível

Citações Citado por

Enviar para

Título:
Clinicopathologic Analysis of Breast Cancers with PIK3CA Mutations in Japanese Women
Autor: MARUYAMA, Naomi ; MIYOSHI, Yasuo ; TAGUCHI, Tetsuya ; TAMAKI, Yasuhiro ; MONDEN, Morito ; NOGUCHI, Shinzaburo
Assuntos: Antineoplastic agents ; Biological and medical sciences ; Breast cancer ; Breast Neoplasms - genetics ; Breast Neoplasms - pathology ; Carcinoma - genetics ; Carcinoma - pathology ; Catalytic Domain ; Class I Phosphatidylinositol 3-Kinases ; Disease-Free Survival ; DNA Mutational Analysis ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Japan ; Lymphatic Metastasis ; Mammary gland diseases ; Medical sciences ; Mutation ; p53 ; pAKT ; Pharmacology. Drug treatments ; Phosphatidylinositol 3-Kinases - genetics ; Phosphatidylinositol 3-Kinases - metabolism ; PIK3CA ; Prognosis ; Receptors, Estrogen - metabolism ; Receptors, Progesterone - metabolism ; Tumors
É parte de: Clinical cancer research, 2007-01, Vol.13 (2), p.408-414
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Descrição: Purpose: Somatic mutations of PIK3CA , which encodes the p110α catalytic subunit of phosphatidylinositol 3-kinase, have recently been shown to play an important role in the pathogenesis and progression of human breast cancers. In this study, the frequency of PIK3CA mutations and their relationship with clinicopathologic and biological variables were investigated in Japanese breast cancers. Experimental Design: Mutational analysis of PIK3CA was done in 188 primary breast cancers of Japanese women. Relationship of these mutations with various clinicopathologic variables [histologic type, tumor size, histologic grade, lymph node status, estrogen receptor (ER)-α and progesterone receptor status, and prognosis], biological variables [phospho-AKT (pAKT) and HER2 expression determined by immunohistochemistry], and p53 mutation status was studied. Results: Missense mutations of PIK3CA were found in 44 of 158 invasive ductal carcinomas, 4 of 10 invasive lobular carcinomas, 1 of 4 mucinous carcinomas, 2 of 2 squamous carcinomas, and 2 of 2 apocrine carcinomas, but no mutation was found in 12 noninvasive ductal carcinomas. PIK3CA -mutated tumors were found to be more likely to be ER-α positive ( P < 0.05) and pAKT positive ( P < 0.05). There was no significant association between PIK3CA mutations and p53 mutation status. PIK3CA mutations were significantly ( P < 0.05) associated with a favorable prognosis, and multivariate analysis showed that PIK3CA mutation status was a significant ( P < 0.05) prognostic factor independent of the other conventional prognostic factors. Conclusions: The frequency of PIK3CA mutations in Japanese breast cancers is similar to that of Caucasian breast cancers. Association of PIK3CA mutations with positive pAKT and positive ER-α suggests that PIK3CA mutations might exert their effects through activation of the phosphatidylinositol 3-kinase/AKT/ER-α pathway. PIK3CA mutations seem to have a potential to be used as an indicator of favorable prognosis.
Editor: Philadelphia, PA: American Association for Cancer Research
Idioma: Inglês

Links

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

Clinicopathologic Analysis of Breast Cancers with PIK3CA Mutations in Japanese Women

MARUYAMA, Naomi ; MIYOSHI, Yasuo ; TAGUCHI, Tetsuya ; TAMAKI, Yasuhiro ; MONDEN, Morito ; NOGUCHI, Shinzaburo

Philadelphia, PA: American Association for Cancer Research

Buscando em bases de dados remotas. Favor aguardar.